World Journal of Gastroenterology - Baishideng Publishing Group

For:	Christodoulidis G, Bartzi D, Koumarelas KE, Kouliou MN. Pembrolizumab in patients with gastric cancer and liver metastases: A paradigm shift in immunotherapy. World J Gastrointest Surg 2024; 16(11): 3391-3394 [PMID: 39649217 DOI: 10.4240/wjgs.v16.i11.3391]
URL:	https://www.wjgnet.com/1007-9327/full/v16/i11/3391.htm

(139) (136) (0) (0) (0) (10) (1998) (1)

Number	Citing Articles
1	Xue-Mei Yi, Hong-Qiao Cai, Yan Jiao. Programmed cell death receptor 1 inhibitor Pembrolizumab in the treatment of advanced gastric cancer. World Journal of Gastrointestinal Surgery 2025; 17(2): 100257 doi: 10.4240/wjgs.v17.i2.100257 Abstract(465) \| Core Tip(518) \| Full Article(HTML)(1221) \| Full Article (PDF)-358K(128) \| Full Article with Cover (PDF)-719K(107) \| Full Article (XML)-64K(111) \| Audio-812K(24) \| Peer-Review Report-447K(118) \| Answering Reviewers-64K(96) \| Times Cited (0) \| Total Visits (1567) \| Open

Number

Citing Articles

Xue-Mei Yi, Hong-Qiao Cai, Yan Jiao. Programmed cell death receptor 1 inhibitor Pembrolizumab in the treatment of advanced gastric cancer. World Journal of Gastrointestinal Surgery 2025; 17(2): 100257 doi: 10.4240/wjgs.v17.i2.100257